News and Updates from the American Society of Clinical Oncology Annual Meeting
For the physicians treating men with non-metastatic castration resistant prostate cancer, knowing the risk of progression or death provides valuable information to guide the timing and selection of treatment.
Physicians and patients want to do everything possible to minimize the risk of breast cancer recurrence without incurring unnecessary toxicity from chemotherapy.
While guidelines for multiple myeloma advise pharmacologic prophylaxis to prevent development of venous thromboembolism (VTE) in high-risk patients, current risk assessment tools differ in the factors considered indicative of high risk and in the patients determined to need preventive anticoagulation.
Multiple organizations have recommended timely treatment for patients with lung cancer.
The treatment armamentarium for renal cell carcinoma and other genitourinary cancers continues to expand.
More than 95,000 Americans develop colon cancer, making it the third most common cancer in the U.S., excluding skin cancers.
Of the more than 28,000 veterans with multiple sclerosis (MS) who receive care at the VHA, almost 45% of them live in rural or highly rural areas, a recent conference presentation pointed out.
While the VA significantly lags behind other healthcare systems in mandating influenza vaccinations for healthcare workers, according to recent research, it is moving closer to the national average because of a directive issued last fall.
Predictions that the influenza vaccine would be largely ineffective in the U.S. based on results seen in Australia the previous summer troubled many federal infectious disease specialists going into last year's flu season.
When time is of the essence, good design saves lives. That was the lesson of a recent experiment in Pittsburgh that tested whether anesthetist trainees would grab the right medication in a stressful simulated operating room scenario or make a potentially fatal mistake.
VA remains on track for implementing its new disability appeals system by the February 2019 deadline, VA officials told lawmakers at a recent hearing.
© 2000-2018. All Materials Copyright Marathon Medical Communications, Inc.